Base Genomics
Base Genomics is an epigenetics company focusing on developing a blood test for early-stage cancer and minimal residual disease.
Total raised
€9.8M
€9,791,100
Funding rounds
1
Investors
1
distinct backers
Active since
2020-03
latest 2020-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-03-06 | Seed | €9.8M | Oxford Sciences Innovation | View deal → |